Shares of XOMA Co. (NASDAQ:XOMAP – Get Free Report) were down 0.6% on Friday . The company traded as low as $25.46 and last traded at $25.46. Approximately 2,916 shares traded hands during trading, an increase of 67% from the average daily volume of 1,745 shares. The stock had previously closed at $25.63.
XOMA Stock Performance
The firm’s fifty day moving average is $25.95 and its 200 day moving average is $25.67.
XOMA Company Profile
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets.
See Also
- Five stocks we like better than XOMA
- Top Biotech Stocks: Exploring Innovation Opportunities
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- Market Cap Calculator: How to Calculate Market Cap
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- What is the Dogs of the Dow Strategy? Overview and Examples
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
